← All indications
Viremia
The presence of viruses in the blood.
Subtype terms (1)
More specific conditions that are subtypes of Viremia in the MeSH hierarchy.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (2)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (20)
- Bristol-Myers Squibb
- Gilead Sciences
- Novartis
- New Discovery LLC
- University of London
- Harvard University
- Federal University of Health Science of Porto Alegre
- New York University
- Capital Medical University
- University of California, San Francisco
- Icahn School of Medicine at Mount Sinai
- Southeast University
- University of Strasbourg
- Janssen Pharmaceutica NV
- Hepatobiliary Disease Hospital of Jilin Province, Jilin, China
- The Fifth Hospital of Shijiazhuang
- University of North Carolina at Chapel Hill
- Nanyang Central Hospital
- People's Liberation Army of China
- Hebei Medical University
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (22)
- ViiV Healthcare
- Merck
- Amplyx Pharmaceuticals
- Atara Biotherapeutics
- Chimerix
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Ospedale San Raffaele
- Andalusian Initiative for Advanced Therapies
- Banc de Sang i Teixits
- Cornell University
- University of Seville
- University of Valencia
- University of Minnesota
- City of Hope National Medical Center
- Cinkate Corp
- Universidad Autonoma de Barcelona
- Vita-Salute University of Milano. Italy
- Andalusian Initiative in Advanced Therapies
- Chang Zheng Hospital
- Andrulis Pharmaceuticals
- Vall d'Hebron Institute of Research, Galatea Clinic
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (7)